Combination therapy reveals potential vulnerability in aggressive osteosarcoma (IMAGE)
Caption
(L to R) Co-corresponding author Adam Durbin, MD, PhD, St. Jude Department of Oncology; co-first authors Yang Zhang, PhD, St. Jude Department of Computational Biology, and Stephanie Nance, PhD, St. Jude Department of Oncology; and co-corresponding author Brian Abraham, PhD, St. Jude Department of Computational Biology.
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content